Polymorphous low-grade neuroepithelial tumor of the young with FGFR3-TACC3 fusion mimicking high-grade glioma: Case report and series of high-grade correlates Journal Article


Authors: Golub, D.; Lynch, D. G.; Pan, P. C.; Liechty, B.; Slocum, C.; Bale, T.; Pisapia, D. J.; Juthani, R.
Article Title: Polymorphous low-grade neuroepithelial tumor of the young with FGFR3-TACC3 fusion mimicking high-grade glioma: Case report and series of high-grade correlates
Abstract: Background: Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a recently described entity that can mimic high-grade glioma (HGG) in histologic and molecular features; however, factors predicting aggressive behavior in these tumors are unclear. Methods: We present an indolent neuroepithelial neoplasm in a 59-year-old female with imaging initially suggestive of HGG, and a series of adult patients with HGG harboring FGFR3-TACC3 fusions are also presented for comparison. Results: Pathology in the case patient revealed low-grade cytomorphology, microcalcifications, unusual neovascularization, and a low proliferation index. The lesion was diffusely CD34+ and harbored an FGFR3-TACC3 fusion and TERT promoter mutation. A diagnosis of PLNTY was therefore favored and the patient was observed with no progression at 15-month follow-up. In patients with HGG with FGFR3-TACC3 fusions, molecular findings included IDH-wildtype status, absence of 1p19q codeletion, CDKN2A loss, TERT promoter mutations and lack of MGMT promoter methylation. These patients demonstrated a median 15-month overall survival and a 6-month progression-free survival. Conclusion: PLNTY is a rare low-grade entity that can display characteristics of HGG, particularly in adults. Presence of FGFR3-TACC3 fusions and other high-grade features should raise concern for a more malignant precursor lesion when a diagnosis of PLNTY is considered. Copyright © 2023 Golub, Lynch, Pan, Liechty, Slocum, Bale, Pisapia and Juthani.
Keywords: immunohistochemistry; adult; clinical article; middle aged; gene mutation; overall survival; case report; radiation dose; nuclear magnetic resonance imaging; glioma; dna damage; cell structure; image analysis; fibroblast growth factor receptor 3; fluorescence in situ hybridization; neutrophil; glioblastoma; fluorodeoxyglucose f 18; neuroepithelioma; oligodendroglioma; external beam radiotherapy; chromosome analysis; diffusion weighted imaging; neovascularization (pathology); chemoradiotherapy; aggression; high-grade glioma; proliferation index; human; female; article; fgfr fusion; glioma molecular drivers; plnty
Journal Title: Frontiers in Oncology
Volume: 13
ISSN: 2234-943X
Publisher: Frontiers Media S.A.  
Date Published: 2023-11-21
Start Page: 1307591
Language: English
DOI: 10.3389/fonc.2023.1307591
PROVIDER: scopus
PMCID: PMC10698862
PUBMED: 38074682
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Tejus Bale
    122 Bale